| MDDCX | VEMAX | MDDCX / VEMAX | |
| Total Expense Ratio | 1.12 | 0.13 | 862% |
| Annual Report Gross Expense Ratio | 1.37 | 0.13 | 1,054% |
| Fund Existence | 32 years | 20 years | - |
| Gain YTD | 20.850 | 9.106 | 229% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | 100 | N/A | - |
| Net Assets | 1.94B | 163B | 1% |
| Annual Yield % from dividends | 6.63 | 2.32 | 286% |
| Returns for 1 year | 42.22 | 19.34 | 218% |
| Returns for 3 years | 54.41 | 46.41 | 117% |
| Returns for 5 years | 22.44 | 27.49 | 82% |
| Returns for 10 years | 127.34 | 89.08 | 143% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MDFGX | 30.49 | 0.46 | +1.53% |
| BlackRock Capital Appreciation Inv A | |||
| OIEQX | 28.62 | 0.24 | +0.85% |
| JPMorgan Equity Income R4 | |||
| GTLOX | 23.84 | 0.06 | +0.25% |
| Glenmede Disciplined US Eq Ptf | |||
| CSDGX | 17.13 | 0.04 | +0.23% |
| Copeland SMID Cap Dividend Growth A | |||
| GTMUX | 24.78 | -0.03 | -0.12% |
| Goldman Sachs Small/Mid Cap Growth R6 | |||